therapeutic silencing microrna primates chronic hepatitis c virus infection
liver-expressed microrna mir- essential hepatitis c virus hcv rna accumulation cultured liver cells potential target antiviral intervention assessed found treatment chronically infected chimpanzees locked nucleic acid lna-modified oligonucleotide spc3649 complementary mir leads long-lasting suppression hcv viremia evidence viral resistance side effects treated animals furthermore transcriptome histological analyses liver biopsies demonstrated derepression target mrnas mir seed sites down-regulation interferon-regulated genes improvement hcv-induced liver pathology prolonged virological response spc3649 treatment without hcv rebound holds promise new antiviral therapy high barrier resistance
